Skip to content

Depression: all studies

Page 99 of 1,034: studies 981 to 990 of 10,336, newest first. Back to the depression overview

Research

Esketamine in Geriatric Depression and Pseudodementia: A Case Study

Clinical Neuropsychopharmacology and Addiction April 2, 2025 Filippo Mazzoni, Giovanni Carnevale Miacca, Alessandro Guffant et al.

Case Report Esketamine in Geriatric Depression and Pseudodementia: A Case Study Filippo Mazzoni 1,2, Giovanni Carnevale Miacca 1,2, Alessandro Guffanti 1,2, Vassilis Martiadis 3, Benardo Maria Dell’Osso 4,5,6,7, Natascia Brondino 1,2 and Miriam Olivola 1,4 1 Department of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, Italy 2 Department of Mental Health and Addiction, ASST...

Triple-network model-based graph theory analysis of the effectiveness of low-dose ketamine in patients with treatment-resistant depression: two resting-state functional MRI clinical trials.

The British Journal of Psychiatry April 2, 2025 Wei-Chen Lin, Li-Kai Cheng, Tung-Ping Su et al. 2 citations

Evidence suggests the crucial role of dysfunctional default mode (DMN), salience and frontoparietal (FPN) networks, collectively termed the triple network model, in the pathophysiology of treatment-resistant depression (TRD). Using the graph theory- and seed-based functional connectivity analyses, we attempted to elucidate the role of low-dose ketamine in the triple networks, namely the DMN,...

DOI: 10.1192/bjp.2025.14 (opens in new tab) Full text (opens in new tab) Treatment-resistant depression Triple-network model Graph theory Resting-state functional connectivity +4

S-ketamine Alleviates Neuroinflammation and Attenuates Lipopolysaccharide-Induced Depression Via Targeting SIRT2.

Advanced Science April 2, 2025 Cong Lin, Xiaoxuan Zhou, Mingqi Li et al. 14 citations

Depression, a pervasive mental health condition, has increasingly been linked to neuroinflammation, as evidenced by elevated levels of pro-inflammatory markers such as TNF-α and IL-1β observed in patients, which underscores the role of inflammation in its pathophysiology. This study investigates the differential effects of S-ketamine (S-KET) and R-ketamine (R-KET) on inflammation-induced...

DOI: 10.1002/advs.202416481 (opens in new tab) Full text (opens in new tab) R‐ketamine S‐ketamine Depression/mental health/mood disorders Ketamine/s-ketamine/esketamine/r-ketamine +2

Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression.

JAMA Psychiatry April 2, 2025 Antonio Del Casale, Sara Spirito, Jan Francesco Arena et al. 17 citations

Treatment-resistant depression (TRD) remains a critical challenge in psychiatry, with limited effective options. Esketamine, a rapid-acting antidepressant, is usually combined with a selective serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI), but comparative evidence of these combinations' effectiveness in real-world settings is sparse. To determine...

DOI: 10.1001/jamapsychiatry.2025.0200 (opens in new tab) Full text (opens in new tab) Depression treatment Esketamine therapy Antidepressants Mental health research +1

Ketamine's Influence on Magnetoencephalography Patterns During a Working Memory Task in Treatment-Resistant Depression: An Exploratory Study.

Bipolar Disorders April 2, 2025 Adam Fijtman, Mani Yavi, Abigail Vogeley et al. 2 citations

Treatment-resistant depression (TRD) remains a challenge, necessitating novel interventions that address associated cognitive deficits. The glutamatergic modulator ketamine exerts rapid antidepressant effects, prompting investigators to assess its impact on cognitive function, specifically working memory. This study explored ketamine's influence on working memory and magnetoencephalography...

DMN network and neurocognitive changes associated with dissociative symptoms in major depressive disorder: a research protocol

Frontiers in Psychiatry April 1, 2025 Asli Ercan Dogan, Herdem Aslan Genç, S. Balaç et al.

Introduction Depression is a heterogeneous disorder with diverse clinical presentations and etiological underpinnings, necessitating the identification of distinct subtypes to enhance targeted interventions. Dissociative symptoms, commonly observed in major depressive disorder (MDD) and linked to early life trauma, may represent a unique clinical dimension associated with specific...

Nightmares and childhood trauma in depression and insomnia among adolescents: A pilot study

European Psychiatry April 1, 2025 Yijun Li, H.F. Sit, Yut-Lin Wong et al.

Introduction Nightmares have been linked to childhood trauma and an increased risk for mental health problems, such as depression. Meanwhile, there is a high comrobdity of nightmares and insomnia. Yet relatively few studies have compared the clinical presentations of nightmares in different clinical groups. Additionally, considering the close association between childhood trauma, insomnia, and...

An examination of the effectiveness of mindfulness-integrated cognitive behavior therapy on depression, anxiety, stress and sleep quality in Iranian women with breast cancer: a randomized controlled trial

Scientific Reports April 1, 2025 Mahboobeh Soleymani Moghadam, Aliakbar Parvizifard, Aliakbar Foroughi et al.

Breast cancer causes numerous physical complications and mental stress that negatively impact patients’ performance and quality of life. This study examined the effects of mindfulness-integrated cognitive behavior therapy (MICBT) on depression, anxiety, stress, and sleep quality in women with breast cancer. A clinical trial design with pre-tests and post-tests and a two-month follow-up were...

From NMDA Receptor Antagonism to Cerebrovascular Effects: The Dual Facets of Nitrous Oxide in Bipolar Depression

European Psychiatry April 1, 2025 C. Pinheiro Ramos, A. F. Reis, C. Batista et al.

IntroductionNitrous oxide (N2O) was first discovered in 1772 by Joseph Priestley. Since its anesthetic properties were realized in 1844, it has been used in the medical and dental fields. Nitrous oxide is also known as “laughing gas” or “nos”.Recent literature suggests that studying N2O is important, not only for understanding the pathophysiology of bipolar depression but also for exploring its...

Descriptive study on esketamine and ketamine treatment in real-world patients with a diagnosis of resistant depression

European Psychiatry April 1, 2025 E. A. Ródenas Vera, S. Sabater, P. Alvarez et al.

IntroductionDepressive disorder is one of the health problems that carries the greatest burden of morbidity, with high prevalence and impact on people’s quality of life. It also affects the family environment and contributes to the social and economic burden on health systems (World Health Organization, depression, 2023). Currently, the treatment of depression has limitations and there is a...